RA Patients Are Receiving Recommended Cancer Screenings

This article originally appeared here.
Share this content:
RA Patients Are Receiving Recommended Cancer Screenings
RA Patients Are Receiving Recommended Cancer Screenings

(HealthDay News) – Patients with rheumatoid arthritis (RA) receive cancer screening tests at higher rates than that of the general population, according to a study published online July 10 in Arthritis & Rheumatism.

Using data from a large US commercial insurance plan, Seoyoung C. Kim, MD, from Brigham and Women's Hospital in Boston, and colleagues compared cancer screening rates for patients with and without RA. RA was identified as two or more diagnoses of RA and at least 1 prescription for a disease-modifying anti-rheumatic drug.

The researchers found that, over a mean of 2.3 years of follow-up, both RA and non-RA patients were screened, on average, once every 3 years for cervical cancer and once every 2 years for breast cancer. Adjusting for age, women with RA were more likely than non-RA patients to receive 1 or more of each of the following tests: Papanicolaou smear (hazard ratio [HR], 1.21; 95% confidence interval [CI], 1.17 – 1.24), mammogram (HR, 1.49; 95% CI, 1.45 – 1.53), and colonoscopy (HR, 1.69; 95% CI, 1.61 – 1.77). Similarly, men with RA were more likely than non-RA patients to receive a colonoscopy (HR, 1.52; 95% CI, 1.40 – 1.64). These results persisted when adjusting for age, number of physician visits, percent of visits made to primary care physicians, and comorbidity index.

"Individuals with RA did not appear to be at risk for receiving fewer cancer screening tests than non-RA patients," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs